Artificial intelligence, drug repurposing and peer review
- 14 September 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 38 (10), 1127-1131
- https://doi.org/10.1038/s41587-020-0686-x
Abstract
No abstract availableKeywords
Funding Information
- Krebsliga Schweiz (BIL KFS 4261-08-2017)
This publication has 34 references indexed in Scilit:
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesBioScience Trends, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Target identification among known drugs by deep learning from heterogeneous networksChemical Science, 2020
- BioBERT: a pre-trained biomedical language representation model for biomedical text miningBioinformatics, 2019
- A Guide to Dictionary-Based Text MiningPublished by Springer Science and Business Media LLC ,2019
- DeepFam: deep learning based alignment-free method for protein family modeling and predictionBioinformatics, 2018
- Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic DataMolecular Pharmaceutics, 2016
- Computational and Practical Aspects of Drug RepositioningASSAY and Drug Development Technologies, 2015
- Lancet retracts 12-year-old article linking autism to MMR vaccinesCMAJ : Canadian Medical Association Journal, 2010
- Autism, inflammatory bowel disease, and MMR vaccineThe Lancet, 1998